Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

11th Oct 2011 16:54

RNS Number : 9956P
GlaxoSmithKline PLC
11 October 2011
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 October 2011 of an increase in their notional interests in Ordinary shares at a price of 1365 pence per Ordinary share and ADRs at a price of $42.37 per ADR following the notional re-investment of the dividend paid to shareholders on 6 October 2011.

 

 

Ordinary shares

ADRs

Mr A P Witty

16,333.149

Dr M M Slaoui

4,489.084

Mr S M Bicknell

1,452.966

Mr J M Clarke

4,066.730

Mrs D P Connelly

2,641.762

Mr M Dunoyer

1,911.604

Mr E J Gray

3,069.056

Mr S A Hussain

4,012.727

Mr W C Louv

1,354.326

Dr D Pulman

2,029.879

Mr D S Redfern

1,871.948

Mr J R Stéphenne

2,352.046

Ms C Thomas

2,698.368

Mr P C Thomson

217.896

Mr D E Troy

2,679.555

Dr P J T Vallance

2,651.523

Ms E Walmsley

1,577.548

Mrs V A Whyte

217.896

 

 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

11 October 2011

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFFFBFEFBL

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77